Ozanimod for treating relapsing-remitting multiple sclerosis

Authors
Category Primary study
JournalPrescriber
Year 2021
This article has no abstract
Epistemonikos ID: 3126ac5330bbc0aa63e4815911861de98a90319b
First added on: Feb 13, 2025